NASDAQ:STSA

Satsuma Pharmaceuticals, Inc.

Stock

USD

Last Close

1.10

07/06 20:00

Market Cap

36.47M

Beta: 0.08

Volume Today

1.83M

Avg: 1.01M

PE Ratio

−0.58

PFCF: −0.74

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22
net income	-5.17M -	-7.35M 42.03%	-28.18M 283.54%	-47.56M 68.81%	-51.17M 7.59%	-70.06M 36.90%
depreciation and amortization	10K -	57K 470%	141K 147.37%	239K 69.50%	393K 64.44%	683K 73.79%
deferred income tax			-124K -	83K 166.94%	1.27M 1,428.92%
stock based compensation	66K -	170K 157.58%	747K 339.41%	4.02M 437.88%	5.36M 33.50%	5.71M 6.36%
change in working capital	521K -	295K 43.38%	-2.36M 899.32%	794K 133.67%	1.10M 38.66%	367K 66.67%
accounts receivables
inventory
accounts payables	363K -	-177K 148.76%	3.98M 2,350.85%	-1.63M 140.79%	-1.21M 25.42%	466K 138.45%
other working capital	158K -	472K 198.73%	-6.34M 1,443.64%	2.42M 138.14%	2.31M 4.38%	-99K 104.28%
other non cash items	254K -	-157K 161.81%	132K 184.08%	102K 22.73%	48K 52.94%	11.78M 24,450%
net cash provided by operating activities	-4.32M -	-6.98M 61.56%	-29.64M 324.54%	-42.33M 42.82%	-43.00M 1.58%	-51.52M 19.81%
investments in property plant and equipment	-58K -	-402K 593.10%	-551K 37.06%	-5.17M 837.39%	-2.03M 60.70%	-472K 76.75%
acquisitions net
purchases of investments			-99.86M -	-34.01M 65.94%	-88.62M 160.59%	-47.77M 46.09%
sales maturities of investments			4.53M -	97.17M 2,045.08%	39.87M 58.97%	91.61M 129.77%
other investing activites
net cash used for investing activites	-58K -	-402K 593.10%	-95.88M 23,749.75%	58.00M 160.49%	-50.78M 187.55%	43.37M 185.41%
debt repayment			-167K -	-2M 1,097.60%	-2M 0%	-1.08M 45.85%
common stock issued			81.44M -	134K 99.84%	75.22M 56,030.60%	9.70M 87.10%
common stock repurchased
dividends paid
other financing activites		10.93M -	61.80M 465.37%	-235K 100.38%	68K 128.94%	122K 79.41%
net cash used provided by financing activities		10.93M -	143.06M 1,208.90%	-2.10M 101.47%	73.28M 3,588.01%	8.74M 88.07%
effect of forex changes on cash
net change in cash	-4.38M -	3.55M 181.00%	17.55M 394.78%	13.57M 22.67%	-20.49M 250.99%	594K 102.90%
cash at beginning of period	6.04M -	1.66M 72.54%	5.21M 213.93%	22.75M 337.18%	36.33M 59.64%	15.84M 56.41%
cash at end of period	1.66M -	5.21M 213.93%	22.75M 337.18%	36.33M 59.64%	15.84M 56.41%	16.43M 3.75%
operating cash flow	-4.32M -	-6.98M 61.56%	-29.64M 324.54%	-42.33M 42.82%	-43.00M 1.58%	-51.52M 19.81%
capital expenditure	-58K -	-402K 593.10%	-551K 37.06%	-5.17M 837.39%	-2.03M 60.70%	-472K 76.75%
free cash flow	-4.38M -	-7.38M 68.60%	-30.19M 308.89%	-47.49M 57.32%	-45.03M 5.19%	-51.99M 15.46%

All numbers in USD (except ratios and percentages)